PSI is one of many organisations that are rooted within statistics and data analytics. As such, we believe that it is important for us to link with other appropriate organisations.
PSI is the association located in the UK for statisticians in the pharmaceutical industry, and therefore we have two representatives on the European Federation of Statisticians in the Pharmaceutical Industry council. EFSPI brings together representatives of statistical associations within Europe.
PSI has a joint award for Statistical Excellence within the Pharmaceutical Industry with the RSS. There are six-monthly meetings between representatives of both organisations to maintain good communication and identify opportunities to work together.
Recently PSI has linked with the Indian Association for Statistics in Clinical Trials (IASCT) and members of IASCT can join PSI at a reduced rate. PSI also welcomes members from any other countries, and from statisticians working in the wider clinical research and healthcare industries.
PSI has representatives on the Council of Biopharmaceutical Statisticians.
The Special Interest Groups include suitable representatives from, and interacts with, other organisations depending on the SIG topic. For instance, the Data Transparency SIG has had discussions with PhUSE members.
The PSI Careers and Academic Liaison Committee (CALC) promotes careers for statisticians and programmers within the pharmaceutical industry, and provides information and insights for those who might want to consider such a career through school and university activities, establishing links with relevant professional groups and via our Careers and Schools/Education websites.
The PSI Regulatory Committee is a joint PSI/EFSPI Committee which aims to provide an industry viewpoint on regulatory issues linked to statistics. This includes promoting best practice, reviewing and collating comments on regulatory policy and guidelines, driving debate on future guidance, and engaging with statisticians in European regulatory agencies, including the EMA Biostatistics Working Party (BSWP), as well as the statistical assessors at the Medicines & Healthcare products Regulatory Agency (MHRA).
PSI recognises that it is part of a wide community and therefore actively engages with the community.
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
PSI are starting a book club! We will be reading/discussing non-technical books relevant to our roles. Participants will be split into smaller groups to network with each other and practice exercises.
Learn from others in the PSI Community who also associate with Imposter Syndrome. They will discuss the topic, give their own personal views and experiences and provide tips to beat it.
Complex Innovative Designs: overview and case studies from FDA pilot program and considerations on master protocols.
Here, we show how to estimate potentially time-varying placebo-controlled vaccine efficacy in this type of staggered vaccination of participants.
R is quickly gaining popularity within the pharmaceutical industry due to it being a very powerful object-orientated language, and is able to produce analyses and high quality graphics. This will be a hands-on interactive course and will utilise the RStudio Cloud development environment.
In just 1 hour, learn about the field of medical statistics and how it plays a crucial role in developing ground-breaking new medicines, vaccines and healthcare products.
Overview and Recent methodological Advances for Identifying Treatment Effect Heterogeneity in Clinical Trials.
Building on the previous webinar series we will present a refresher on the key elements of the estimand framework and use the ETHOS study.
Our annual PSI Medical Statistics Careers Event, will be held online on Wednesday 2nd March 2022. The event will include a live online panel discussion and a virtual exhibition session.
For our global team in Europe we are seeking highly qualified candidates to fill the position of Global Director Biostatistics (m/f/x).
Joining us as Principal Biostatistician you will be responsible for providing statistical support of global clinical development programs in neuroscience.
The Senior Manager Biostatistics will be responsible for leading biostatistics strategy and activities for a compound and/or for individual clinical studies.
Novartis is establishing a virtual Analytics Network in the UK and we are currently recruiting PhD graduates to join this exciting new group!
